2 3 study imerge mf pilot studyessential thrombocythemiaimetelstatjanssen collaborationdeveloping imetelstatabout hematologic malignanciespresentations & publicationsinnovative approachestelomerasenucleic acid chemistrypatentsglossaryinvestor relationspress releaseseventsstock informationfundamentalsfinancial reportscorporate governanceinvestor contactsinvestor faqsemail alertsworking with usbenefitsopportunities working with passion integrity & true innovation developing novel first in class therapeutics targeting major unmet medical needs changing the approach totreating cancer imetelstat first in class first in clinic telomerase inhibitor telomerase learn about our innovative approach to developing a treatment for cancer geron announces collaboration with janssen click here for important information & nbsp & nbsp & nbsp geron news9 .12.2016 geron provides update on imetelstat trials being conducted by janssenread more9 .11.2016 geron announces conference call on september 12 at 8 00 a.m. eastern timeread more8 .3.2016 geron corporation reports second quarter 2016 financial results and recent eventsread more events09 .12.2016 geron conference call listen to webcast 08.03.2016 geron q2 2016 conference call listen to webcast 05.17.2016 geron 2016 annual meeting learn more copyright 2016 geron terms of use privacy policy